KODHealthcareSmall-Cap
Kodiak Sciences Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Kodiak Sciences Inc. (KOD), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are KOD insiders buying or selling?
Kodiak Sciences Inc. insiders reported 24 open-market buys ($541.3M) and 45 sells ($35.9M) across 69 Form 4 filings — a net buying position of $505.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 5, 2026)
Total Form 4 filings
69
SEC EDGAR
Insider filers
7
Insider buys (24)
$541.3M
Insider sells (45)
$35.9M
Insider sentiment
Net buyingNet insider flow of $505.4M in net buying.
Recent KOD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | John A. Borgeson | Chief Financial Officer | Sale | 30.0K | $34.10 | $1.0M |
| Apr 3, 2026 | John A. Borgeson | Chief Financial Officer | Sale | 30.0K | $39.92 | $1.2M |
| Dec 19, 2025 | Felix Baker | Director, 10% Owner | Purchase | 2.6M | $23.00 | $60.0M |
| Jun 18, 2025 | John A. Borgeson | Executive Vice President and Chief Financial Officer | Sale | 723 | $3.65 | $2.6K |
| Jun 18, 2024 | John A. Borgeson | Executive Vice President and Chief Financial Officer | Sale | 2.9K | $2.75 | $7.9K |
| Jun 13, 2024 | John A. Borgeson | Executive Vice President and Chief Financial Officer | Sale | 1.6K | $2.92 | $4.5K |
| Jun 17, 2023 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 3.4K | $9.29 | $31.5K |
| Jun 17, 2023 | John A. Borgeson | Executive Vice President and Chief Financial Officer | Sale | 4.2K | $9.30 | $39.0K |
| Jun 6, 2022 | Julian Baker | Director, 10% Owner | Purchase | 572.3K | $7.77 | $4.4M |
| May 27, 2022 | Julian Baker | Director, 10% Owner | Purchase | 350.4K | $6.75 | $2.4M |
| May 18, 2022 | Julian Baker | Director, 10% Owner | Purchase | 456.7K | $5.91 | $2.7M |
| Mar 1, 2022 | PERLROTH VICTOR | Chairman and CEO | Sale | 1.3M | $9.15 | $12.3M |
| Feb 17, 2022 | Julian Baker | Director, 10% Owner | Purchase | 401.0K | $54.45 | $21.8M |
| Jan 31, 2022 | Julian Baker | Director, 10% Owner | Purchase | 347.7K | $52.02 | $18.1M |
| Jan 25, 2022 | Julian Baker | Director, 10% Owner | Purchase | 501.1K | $57.49 | $28.8M |
| Jan 24, 2022 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $64.39 | $447.5K |
| Dec 22, 2021 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $87.60 | $608.8K |
| Nov 24, 2021 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $99.15 | $689.1K |
| Nov 12, 2021 | John A. Borgeson | Senior VP and Chief Financial Officer | Sale | 876 | $115.42 | $101.1K |
| Oct 22, 2021 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $111.77 | $776.8K |
| Oct 1, 2021 | Felix Baker | Director, 10% Owner | Purchase | 86.9K | $95.83 | $8.3M |
| Sep 22, 2021 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $99.88 | $694.2K |
| Sep 17, 2021 | Felix Baker | Director, 10% Owner | Purchase | 31.8K | $94.39 | $3.0M |
| Sep 9, 2021 | Felix Baker | Director, 10% Owner | Purchase | 57.5K | $93.31 | $5.4M |
| Aug 24, 2021 | Jason Ehrlich | Chief Medical Officer and Chief Development Officer | Sale | 7.0K | $91.44 | $635.5K |
Showing the 25 most recent of 69 Form 4 filings for Kodiak Sciences Inc..
Most active KOD insiders
- Jason Ehrlich31 filings
- Felix Baker22 filings
- John A. Borgeson10 filings
- Hong Liang3 filings
- PERLROTH VICTOR1 filing
Ask anything about KOD insider activity
Use Trabud's AI agent to query Kodiak Sciences Inc.'s Form 4 history in plain English — "Show me KOD CEO purchases this year" or compare it against any other ticker.
Open the AI agentKOD insider trading FAQ
Are Kodiak Sciences Inc. insiders buying or selling?
Across 69 SEC Form 4 filings, Kodiak Sciences Inc. (KOD) insiders reported 24 open-market purchases totaling $541.3M and 45 sales totaling $35.9M. That is a net buying position of $505.4M.
How many insiders trade KOD stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Kodiak Sciences Inc.. The most recent filing was accepted on Jun 5, 2026.
Where does Trabud get KOD insider trading data?
All KOD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.